Document is current
Any future updates will be listed below
-
Authors
Khoramnia, Ramin https://orcid.org/0000-0002-6237-7773
Kahraman, Guenal
Amon, Michael
Łabuz, Grzegorz
Baur, Isabella D.
Auffarth, Gerd U.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 20 September 2023
Revised: 1 August 2024
Accepted: 16 August 2024
First Online: 11 September 2024
Declarations
:
: Not applicable for a review paper.
: Not applicable. No human patients were involved in this review paper
: Not applicable. No human participants and/or animals were involved in this review paper.
: Ramin Khoramnia reports grants, personal fees, and non-financial support from Alcon, Johnson & Johnson, Hoya, Physiol, Rayner, personal fees, and non-financial support from Kowa, Ophtec, Oculentis/Teleon, Santen, and Acufocus, outside the submitted work.Michael Amon is a consultant to Rayner Intraocular Lenses Ltd.Gerd U Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson & Johnson and Alcon, grants, personal fees, and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, Ursa-pharm, grants and personal fees from Biotech, Oculus, EyeYon grants from Acufocus, Contamac, Glaukos, Physiol and Rheacell, outside the submitted work.Guenal Kahraman, Grzegorz Łabuz and Isabella D Baur certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
